Prvi slučaj izolovane metastaze primarnog karcinoma prelaznih ćelija jajnika u slezinu

  • Ranko Lazović Clinical Center of Montenegro, Center for Digestive Surgery, Podgorica, Montenegro
  • Batrić Vukčević Clinical Center of Montenegro, Center for Digestive Surgery, Podgorica, Montenegro
  • Petar Milić General Hospital Kotor, General Surgery Department, Kotor, Montenegro
  • Jelena Lazović Clinical Center of Montenegro, Department of Neurology, Podgorica, Montenegro
Ključne reči: karcinom prelaznih ćelija, dijagnoza, histološke tehnike, neoplazme, metastaze, jajnik, neoplazme, slezina

Sažetak


Uvod. Primarni karcinom prelaznih ćelija (KPĆ) jajnika karakteriše prisustvo papilarnih projekcija malignih ćelija prelaznog epitela ili njihovih agregata u fibroznoj stromi. Ovaj tip tumora obuhvata oko 1% svih karcinoma površinskog epitela jajnika. Prikazali smo prvi slučaj solitarne metastaze primarnog ovarijalnog KPĆ u slezinu. Prikaz bolesnika. Bolesnica stara 60 godina primljena je u decembru 2018. godine, zbog asimptomatskog tumora slezine. Dve godine ranije joj je zbog primarnog KPĆ jajnika urađena totalna abdominalna histerektomija, bilateralna adneksektomija i infrakolična omentektomija. Kontrolna ultrasonografija abdomena, kompjuterizovana tomografija i magnetna rezonanca, sprovedene dve godine nakon operacije, pokazale su tumor slezine. Urađena je otvorena splenektomija, a intraoperativni nalaz je pokazao tumor hilusa slezine, bez drugih patoloških lezija u abdomenu. Patohistološka analiza je pokazala metastazu KPĆ, što je potvrđeno naknadnom definitivnom patohistološkom analizom. U toku jednogodišnjeg praćenja nije bilo relapsa bolesti. Zaključak. Prema literaturnim podacima ovo je prvi prikazani slučaj solitarne metastaze primarnog KPĆ jajnika u slezinu, koji može predstavljati primer dijagnostičke i terapijske uloge splenektomije kod izolovanih metastaza karcinoma jajnika u slezinu.

Reference

800x600

Normal

0

false

false

false

EN-US

X-NONE

X-NONE

MicrosoftInternetExplorer4

DefSemiHidden="false" DefQFormat="false" DefPriority="99"

LatentStyleCount="371">

UnhideWhenUsed="true" QFormat="true" Name="heading 2"/>

UnhideWhenUsed="true" QFormat="true" Name="heading 3"/>

UnhideWhenUsed="true" QFormat="true" Name="heading 4"/>

UnhideWhenUsed="true" QFormat="true" Name="heading 5"/>

UnhideWhenUsed="true" QFormat="true" Name="heading 6"/>

UnhideWhenUsed="true" QFormat="true" Name="heading 7"/>

UnhideWhenUsed="true" QFormat="true" Name="heading 8"/>

UnhideWhenUsed="true" QFormat="true" Name="heading 9"/>

Name="index 1"/>

Name="index 2"/>

Name="index 3"/>

Name="index 4"/>

Name="index 5"/>

Name="index 6"/>

Name="index 7"/>

Name="index 8"/>

Name="index 9"/>

UnhideWhenUsed="true" Name="toc 1"/>

UnhideWhenUsed="true" Name="toc 2"/>

UnhideWhenUsed="true" Name="toc 3"/>

UnhideWhenUsed="true" Name="toc 4"/>

UnhideWhenUsed="true" Name="toc 5"/>

UnhideWhenUsed="true" Name="toc 6"/>

UnhideWhenUsed="true" Name="toc 7"/>

UnhideWhenUsed="true" Name="toc 8"/>

UnhideWhenUsed="true" Name="toc 9"/>

Name="Normal Indent"/>

Name="footnote text"/>

Name="annotation text"/>

Name="header"/>

Name="footer"/>

Name="index heading"/>

UnhideWhenUsed="true" QFormat="true" Name="caption"/>

Name="table of figures"/>

Name="envelope address"/>

Name="envelope return"/>

Name="footnote reference"/>

Name="annotation reference"/>

Name="line number"/>

Name="page number"/>

Name="endnote reference"/>

Name="endnote text"/>

Name="table of authorities"/>

Name="macro"/>

Name="toa heading"/>

Name="List"/>

Name="List Bullet"/>

Name="List Number"/>

Name="List 2"/>

Name="List 3"/>

Name="List 4"/>

Name="List 5"/>

Name="List Bullet 2"/>

Name="List Bullet 3"/>

Name="List Bullet 4"/>

Name="List Bullet 5"/>

Name="List Number 2"/>

Name="List Number 3"/>

Name="List Number 4"/>

Name="List Number 5"/>

Name="Closing"/>

Name="Signature"/>

UnhideWhenUsed="true" Name="Default Paragraph Font"/>

Name="Body Text"/>

Name="Body Text Indent"/>

Name="List Continue"/>

Name="List Continue 2"/>

Name="List Continue 3"/>

Name="List Continue 4"/>

Name="List Continue 5"/>

Name="Message Header"/>

Name="Salutation"/>

Name="Date"/>

Name="Body Text First Indent"/>

Name="Body Text First Indent 2"/>

Name="Note Heading"/>

Name="Body Text 2"/>

Name="Body Text 3"/>

Name="Body Text Indent 2"/>

Name="Body Text Indent 3"/>

Name="Block Text"/>

Name="Hyperlink"/>

Name="FollowedHyperlink"/>

Name="Document Map"/>

Name="Plain Text"/>

Name="E-mail Signature"/>

Name="HTML Top of Form"/>

Name="HTML Bottom of Form"/>

Name="Normal (Web)"/>

Name="HTML Acronym"/>

Name="HTML Address"/>

Name="HTML Cite"/>

Name="HTML Code"/>

Name="HTML Definition"/>

Name="HTML Keyboard"/>

Name="HTML Preformatted"/>

Name="HTML Sample"/>

Name="HTML Typewriter"/>

Name="HTML Variable"/>

Name="Normal Table"/>

Name="annotation subject"/>

Name="No List"/>

Name="Outline List 1"/>

Name="Outline List 2"/>

Name="Outline List 3"/>

Name="Table Simple 1"/>

Name="Table Simple 2"/>

Name="Table Simple 3"/>

Name="Table Classic 1"/>

Name="Table Classic 2"/>

Name="Table Classic 3"/>

Name="Table Classic 4"/>

Name="Table Colorful 1"/>

Name="Table Colorful 2"/>

Name="Table Colorful 3"/>

Name="Table Columns 1"/>

Name="Table Columns 2"/>

Name="Table Columns 3"/>

Name="Table Columns 4"/>

Name="Table Columns 5"/>

Name="Table Grid 1"/>

Name="Table Grid 2"/>

Name="Table Grid 3"/>

Name="Table Grid 4"/>

Name="Table Grid 5"/>

Name="Table Grid 6"/>

Name="Table Grid 7"/>

Name="Table Grid 8"/>

Name="Table List 1"/>

Name="Table List 2"/>

Name="Table List 3"/>

Name="Table List 4"/>

Name="Table List 5"/>

Name="Table List 6"/>

Name="Table List 7"/>

Name="Table List 8"/>

Name="Table 3D effects 1"/>

Name="Table 3D effects 2"/>

Name="Table 3D effects 3"/>

Name="Table Contemporary"/>

Name="Table Elegant"/>

Name="Table Professional"/>

Name="Table Subtle 1"/>

Name="Table Subtle 2"/>

Name="Table Web 1"/>

Name="Table Web 2"/>

Name="Table Web 3"/>

Name="Balloon Text"/>

Name="Table Theme"/>

Name="List Paragraph"/>

Name="Intense Quote"/>

Name="Subtle Emphasis"/>

Name="Intense Emphasis"/>

Name="Subtle Reference"/>

Name="Intense Reference"/>

UnhideWhenUsed="true" Name="Bibliography"/>

UnhideWhenUsed="true" QFormat="true" Name="TOC Heading"/>

Name="Grid Table 1 Light Accent 1"/>

Name="Grid Table 6 Colorful Accent 1"/>

Name="Grid Table 7 Colorful Accent 1"/>

Name="Grid Table 1 Light Accent 2"/>

Name="Grid Table 6 Colorful Accent 2"/>

Name="Grid Table 7 Colorful Accent 2"/>

Name="Grid Table 1 Light Accent 3"/>

Name="Grid Table 6 Colorful Accent 3"/>

Name="Grid Table 7 Colorful Accent 3"/>

Name="Grid Table 1 Light Accent 4"/>

Name="Grid Table 6 Colorful Accent 4"/>

Name="Grid Table 7 Colorful Accent 4"/>

Name="Grid Table 1 Light Accent 5"/>

Name="Grid Table 6 Colorful Accent 5"/>

Name="Grid Table 7 Colorful Accent 5"/>

Name="Grid Table 1 Light Accent 6"/>

Name="Grid Table 6 Colorful Accent 6"/>

Name="Grid Table 7 Colorful Accent 6"/>

Name="List Table 1 Light Accent 1"/>

Name="List Table 6 Colorful Accent 1"/>

Name="List Table 7 Colorful Accent 1"/>

Name="List Table 1 Light Accent 2"/>

Name="List Table 6 Colorful Accent 2"/>

Name="List Table 7 Colorful Accent 2"/>

Name="List Table 1 Light Accent 3"/>

Name="List Table 6 Colorful Accent 3"/>

Name="List Table 7 Colorful Accent 3"/>

Name="List Table 1 Light Accent 4"/>

Name="List Table 6 Colorful Accent 4"/>

Name="List Table 7 Colorful Accent 4"/>

Name="List Table 1 Light Accent 5"/>

Name="List Table 6 Colorful Accent 5"/>

Name="List Table 7 Colorful Accent 5"/>

Name="List Table 1 Light Accent 6"/>

Name="List Table 6 Colorful Accent 6"/>

Name="List Table 7 Colorful Accent 6"/>

/* Style Definitions */

table.MsoNormalTable

{mso-style-name:"Table Normal";

mso-tstyle-rowband-size:0;

mso-tstyle-colband-size:0;

mso-style-noshow:yes;

mso-style-priority:99;

mso-style-parent:"";

mso-padding-alt:0cm 5.4pt 0cm 5.4pt;

mso-para-margin:0cm;

mso-para-margin-bottom:.0001pt;

mso-pagination:widow-orphan;

font-size:10.0pt;

font-family:"Times New Roman",serif;}

1.      Badin J, Abello A, Gupta M, Das AK. Urothelial Carcinoma of the Bladder With a Rare Solitary Metastasis to the Ovary. Urology 2020; 135: 24‒7.

2.      Cuatrecasas M, Catasus L, Palacios J, Prat J. Transitional cell tumors of the ovary: a comparative clinicopathologic, immunohistochemical, and molecular genetic analysis of Brenner tumors and transitional cell carcinomas. Am J Surg Pathol 2009; 33(4): 556‒67.

3.     Weinberger V, Minář L, Felsinger M, Ovesná P, Bednaříková M, Číhalová M, et al. Brenner tumor of the ovary – ultrasound features and clinical management of a rare ovarian tumor mimicking ovarian cancer. Ginekol Pol 2018; 89(7): 357‒63.

4.      Giordano G, D'Adda T, Gnetti L, Merisio C, Raboni S. Transitional cell carcinoma of the endometrium associated with benign ovarian brenner tumor: a case report with immunohistochemistry molecular analysis and a review of the literature. Int J Gynecol Pathol 2007; 26(3): 298‒304.

5.      Austin RM, Norris HJ. Malignant Brenner tumor and transitional cell carcinoma of the ovary: a comparison. Int J Gynecol Pathol 1987; 6(1): 29‒39.

6.      Chandanwale SS, Kamble T, Mishra N, Kumar H, Jadhav R. A pure primary transitional cell carcinoma of the ovary: A rare case report with literature review. Int J Appl Basic Med Res 2016; 6(2): 140‒2.

7.      Kommoss F, Kommoss S, Schmidt D, Trunk MJ, Pfisterer J, du Bois A, et al. Survival benefit for patients with advanced-stage transitional cell carcinomas vs. other subtypes of ovarian carcinoma after chemotherapy with platinum and paclitaxel. Gynecol Oncol 2005; 97(1): 195‒9.

8.     Eichhorn JH, Young RH. Transitional cell carcinoma of the ovary: a morphologic study of 100 cases with emphasis on differential diagnosis. Am J Surg Pathol 2004; 28(4): 453‒63.

9.      Logani S, Oliva E, Amin MB, Folpe AL, Cohen C, Young RH. Immunoprofile of ovarian tumors with putative transitional cell (urothelial) differentiation using novel urothelial markers: histogenetic and diagnostic implications. Am J Surg Pathol 2003; 27(11): 1434‒41.

10.   Ichigo S, Takagi H, Matsunami K, Murase T, Ikeda T, Imai A. Transitional cell carcinoma of the ovary (Review). Oncol Lett 2012; 3(1): 3-6. (English)

11.   Silva EG, Robey-Cafferty SS, Smith TL, Gershenson DM. Ovarian carcinomas with transitional cell carcinoma pattern. Am J Clin Pathol 1990; 93(4):457-65.

12.   Keepanasseril A, Suri V, Gupta N, Ghoshal S. Transitional cell carcinoma of the ovary: unusual presentation as metastatic cervical lymph node. J Obstet Gynaecol Res 2008; 34(4 Pt 2): 696‒8.

13.   Ghani AA, Hashmi ZA, Chase DM, Patel SB, Jones DF. Intraparenchymal metastases to the spleen from ovarian cancer: a case report. J Med Case Rep 2010; 4: 30.

14.   Farias-Eisner R, Braly P, Berek JS. Solitary recurrent metastasis of epithelial ovarian cancer in the spleen. Gynecol Oncol 1993; 48(3): 338‒41.

15.   Izuishi K, Sano T, Usuki H, Okano K, Masaki T, Kushida Y, et al. Isolated splenic metastasis of ovarian cancer 20 years after operation: a case report and literature review. Tumori 2010; 96(5): 784‒6.

16.   Gemignani ML, Chi DS, Gurin CC, Curtin JP, Barakat RR. Splenectomy in recurrent epithelial ovarian cancer. Gynecol Oncol 1999; 72(3): 407‒10.

17.   Yano H, Iwazawa T, Kinuta M, Nakano Y, Tono T, Matsui S, et al. Solitary splenic metastasis from ovarian cancer successfully treated by hand-assisted laparoscopic splenectomy: report of a case. Surg Today 2002; 32(8): 750‒2.

18.   Koh YS, Kim JC, Cho CK. Splenectomy for solitary splenic metastasis of ovarian cancer. BMC Cancer 2004; 4(1): 96.

19.  Tserkezoglou A, Kontou S, Hatjieleftheriou G, Nikolaidou ME, Plataniotis G, Apostolikas N, et al. Solitary parenchymal splenic recurrence of ovarian adenocarcinoma: a case report and review of the literature. Anticancer Res 2005; 25(2B): 1471‒6.

20.   Otrock ZK, Seoud MA, Khalifeh MJ, Makarem JA, Shamseddine AI. Laparoscopic splenectomy for isolated parenchymal splenic metastasis of ovarian cancer. Int J Gynecol Cancer 2006; 16(5): 1933‒5.

21.   Karni D, Kopelman D, Abu Hatoum O. Solitary splenic metastasis of ovarian carcinoma: a case report. J Med Case Rep 2014; 8: 154.

22.   Lee DH, Yoon JK, Lee SJ, Jo KS, Yoon SH, An YS. Isolated splenic metastasis of ovarian cancer detected with 18F-FDG PET/CT. Clin Nucl Med 2014; 39(4): 349‒51.

23.   Resta G, Vedana L, Marino S, Scagliarini L, Bandi M, Anania G. Isolated splenic metastasis of ovaric cancer. Case report and literature review. G Chir 2014; 35(7‒8): 181‒4.

24.   Lv M, Li Y, Luo C, Liu P, Yang J. Splenic metastasis of ovarian clear cell adenocarcinoma: A case report and review of the literature. Exp Ther Med 2014; 7(4): 982‒6.

25.   Sorbi F, Prosperi P, Villanucci A, Berti V, Sisti G, Fambrini M. Laparoscopic Splenectomy as Quaternary Cytoreduction for Isolated Parenchymal Splenic Recurrence of Epitelial Tubo-Ovarian Cancer: Report of a Case and Literature Review. Gynecol Obstet Invest 2015; 80(4): 265‒71.

26.   Max LD, Stastny JF, Frable WJ. Solitary splenic metastasis of an adenocarcinoma of the ovaries. Gynecol Obstet Invest 1996; 42(3): 214‒6.

27.  Tazi EM, Lalya I, Tazi MF, Ahellal Y, M'rabti H, Errihani H. Transitional cell carcinoma of the ovary: a rare case and review of literature. World J Surg Oncol 2010; 8: 98. (English)

28.   Lee M, Jung YW, Kim SW, Kim SH, Kim YT. Metastasis to the ovaries from transitional cell carcinoma of the bladder and renal pelvis: a report of two cases. J Gynecol Oncol 2010; 21(1): 59‒61.

29.   Coffman LG, Burgos-Ojeda D, Wu R, Cho K, Bai S, Buckanovich RJ. New models of hematogenous ovarian cancer metastasis demonstrate preferential spread to the ovary and a requirement for the ovary for abdominal dissemination. Transl Res 2016; 175: 92‒102. e2.

30.   Yousefi M, Dehghani S, Nosrati R, Ghanei M, Salmaninejad A, Rajaie S, et al. Current insights into the metastasis of epithelial ovarian cancer - hopes and hurdles. Cell Oncol 2020; 43(4): 515‒38.

31.   Giannopoulou L, Kasimir-Bauer S, Lianidou ES. Liquid biopsy in ovarian cancer: recent advances on circulating tumor cells and circulating tumor DNA. Clin Chem Lab Med 2018; 56(2): 186‒97.

32.   Ramalingam P. Morphologic, Immunophenotypic, and Molecular Features of Epithelial Ovarian Cancer. Oncology (Williston Park) 2016; 30(2): 166‒76.

Objavljeno
2022/11/01
Rubrika
Prikaz bolesnika